
MedStat AI Inc. is advancing diagnostics and personalized medicine through an AI-powered clinical decision support platform. Its first initiative focuses on developing a regulatory-grade software as a medical device system that leverages multimodal, hospital-grade data to enable faster, more accurate, and patient-tailored assessments. Designed to be device-agnostic, cloud-deployable, and seamlessly integrated into existing clinical workflows, the platform expands access while reducing diagnostic delays.
Portfolio Companies
- Anaco
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- Diatom Biolab
- Eximius Diagnostics
- Giant BioSystems
- Hikari Medical Technologies
- ImmunoVec
- MedStat AI Inc.
- Mervyn's Petcare, Inc.
- Meteor Biotech, LLC
- My Block Skin, Inc.
- Nanomega CryoAI
- NEXT-TFX, Inc.
- Paralos Bioscience Inc.
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Prosper DNA
- Protean Research, Inc.
- Purpose Bio
- RaizDx
- RiboForge
- Saku Biosciences, Inc.
- SolGrapH, Inc.
- Sorriso Pharmaceuticals
- Thermeutics, Inc.
- Vault Pharma
- Veergen, Inc.
- Yuyu Bio, Inc.